159938 医药
已收盘 09-28 15:00:00
资讯
新帖
简况
劲方医药-B9月28日回购11.60万股，耗资318.55万港元
同花顺 · 34分钟前
劲方医药-B9月28日回购11.60万股，耗资318.55万港元
上海思璞锐医药与默沙东达成全球独家授权 首付款4亿美元
第一财经 · 19:59
上海思璞锐医药与默沙东达成全球独家授权 首付款4亿美元
再次突围！药ETF华宝（562050）标的指数逆市收红，器械巨头力挺，512170韧劲十足！医药抗跌力从何而来？
新浪基金 · 19:46
再次突围！药ETF华宝（562050）标的指数逆市收红，器械巨头力挺，512170韧劲十足！医药抗跌力从何而来？
劲方医药9月28日回购11.6万股H股 耗资约318.6万港元
同花顺 · 19:38
劲方医药9月28日回购11.6万股H股 耗资约318.6万港元
甘肃农垦药物碱厂与广州安信医药有限公司座谈交流
市场资讯 · 18:09
甘肃农垦药物碱厂与广州安信医药有限公司座谈交流
劲方医药-B斥资318.55万港元回购11.6万股
同花顺 · 18:05
劲方医药-B斥资318.55万港元回购11.6万股
劲方医药-B9月28日斥资318.55万港元回购11.6万股
同花顺 · 17:59
劲方医药-B9月28日斥资318.55万港元回购11.6万股
劲方医药-B(02595)9月28日斥资318.55万港元回购11.6万股
智通财经 · 17:53
劲方医药-B(02595)9月28日斥资318.55万港元回购11.6万股
9月28日亚虹医药科技跌6.92%，国联医疗健康混合A基金重仓该股
证券之星 · 16:42
9月28日亚虹医药科技跌6.92%，国联医疗健康混合A基金重仓该股
云顶新耀盘中涨超5%，AI医药规划发布及mRNA疫苗进展
同花顺 · 13:24
云顶新耀盘中涨超5%，AI医药规划发布及mRNA疫苗进展
医药韧性凸显！药ETF华宝（562050）逆市飘红，丽珠集团涨停！医疗器械局部强势，迈瑞、联影携手走强
新浪基金 · 13:11
医药韧性凸显！药ETF华宝（562050）逆市飘红，丽珠集团涨停！医疗器械局部强势，迈瑞、联影携手走强
礼邦医药-B盘中跌超5%
同花顺 · 13:03
礼邦医药-B盘中跌超5%
同源康医药-B盘中跌超5%，董事长连续增持，齐鲁股权认购失效
同花顺 · 12:04
同源康医药-B盘中跌超5%，董事长连续增持，齐鲁股权认购失效
劲方医药-B盘中跌超5%
同花顺 · 10:39
劲方医药-B盘中跌超5%
星昊医药（920017）57.52万股限售股将于9月28日解禁，占总股本0.46%
证券之星 · 08:01
星昊医药（920017）57.52万股限售股将于9月28日解禁，占总股本0.46%
股市必读：欧康医药新发布《投资者关系活动记录表》
证券之星 · 03:44
股市必读：欧康医药新发布《投资者关系活动记录表》
股市必读：迪哲医药新发布《迪哲医药：关于高级管理人员减持股份计划公告》
证券之星 · 01:30
股市必读：迪哲医药新发布《迪哲医药：关于高级管理人员减持股份计划公告》
股市必读：津药药业新发布《津药药业股份有限公司关于上海上实（集团）有限公司及上海上实投资发展有限公司挂牌转让上海琉璃光医药发展有限公司100%股权的提示性公告》
证券之星 · 01:09
股市必读：津药药业新发布《津药药业股份有限公司关于上海上实（集团）有限公司及上海上实投资发展有限公司挂牌转让上海琉璃光医药发展有限公司100%股权的提示性公告》
年内外资调研A股公司近6000次 外资机构调研路径呈现科技为主，消费、医药为辅的格局
东方财富网 · 00:39
年内外资调研A股公司近6000次 外资机构调研路径呈现科技为主，消费、医药为辅的格局
国泰海通｜医药：WCLC大会：中国公司展现强劲竞争力
国泰君安证券研究 · 09-27 22:33
国泰海通｜医药：WCLC大会：中国公司展现强劲竞争力
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"159938","market":"SZ","secType":"STK","nameCN":"医药","latestPrice":0.636,"timestamp":1790579004000,"preClose":0.638,"halted":0,"volume":52131900,"delay":0,"changeRate":-0.0031,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.002,"latestTime":"09-28 15:00:00","open":0.638,"high":0.643,"low":0.633,"amount":33227500,"amplitude":0.0157,"askPrice":0.638,"askSize":1577,"bidPrice":0.636,"bidSize":3468,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790645400000},"marketStatusCode":5,"adr":0,"adjPreClose":0.638,"symbolType":"fund","openAndCloseTimeList":[[1790559000000,1790566200000],[1790571600000,1790578800000]],"highLimit":0.702,"lowLimit":0.574,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":0.046431,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/159938/","defaultTab":"news","newsList":[{"id":"2670258526","title":"劲方医药-B9月28日回购11.60万股，耗资318.55万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670258526","media":"同花顺","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670258526?lang=zh_cn&edition=full","pubTime":"2026-09-28 21:25","pubTimestamp":1790601900,"startTime":"0","endTime":"0","summary":"证券时报.数据宝统计，劲方医药-B在港交所公告显示，9月28日以每股26.980港元至27.960港元的价格回购11.60万股，回购金额达318.55万港元。该股当日收盘价27.400港元，下跌8.36%，全天成交额 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260928/c680334501.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260928/c680334501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232287","title":"上海思璞锐医药与默沙东达成全球独家授权 首付款4亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232287","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670232287?lang=zh_cn&edition=full","pubTime":"2026-09-28 19:59","pubTimestamp":1790596779,"startTime":"0","endTime":"0","summary":"【上海思璞锐医药与默沙东达成全球独家授权 首付款4亿美元】9月28日，上海思璞锐医药科技有限公司（SciBrunch Therapeutics Co., Ltd.，以下简称“思璞锐”）与默沙东（默沙东为美国新泽西州罗威市默克公司的公司商号）共同宣布，双方就在研口服KRAS G12D（ON）抑制剂SPR2015达成全球独家授权协议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609283885360447.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609283885360447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","09939","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670344192","title":"再次突围！药ETF华宝（562050）标的指数逆市收红，器械巨头力挺，512170韧劲十足！医药抗跌力从何而来？","url":"https://stock-news.laohu8.com/highlight/detail?id=2670344192","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670344192?lang=zh_cn&edition=full","pubTime":"2026-09-28 19:46","pubTimestamp":1790595960,"startTime":"0","endTime":"0","summary":"医疗ETF华宝跟踪的中证医疗指数微跌0.14%。截至收盘，药ETF华宝、医疗ETF华宝标的指数市盈率TTM分别为29.12倍、30.46倍，位于近10年10.86%、25.44%分位点，估值水平处于历史相对低位。药ETF华宝、医疗ETF华宝基金经理张放指出，医药投资主线或正从前期的“低估修复”，转向“创新兑现”驱动，同时AIDD产业链提供新增结构性机会。医疗ETF华宝：医药医疗类ETF旗舰，二季报规模256.24亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-28/doc-initktpc3633274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["562050","BK1161","512170","BK1515","09939","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670450234","title":"劲方医药9月28日回购11.6万股H股 耗资约318.6万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670450234","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670450234?lang=zh_cn&edition=full","pubTime":"2026-09-28 19:38","pubTimestamp":1790595480,"startTime":"0","endTime":"0","summary":"9月28日，劲方医药-B(02595.HK)于2026年9月28日在香港联交所回购11.6万股H股，回购股份持作库存股份，每股最高回购价HKD27.96，最低回购价HKD26.98，付出价格总额HKD318.55万。 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260928/c680329964.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260928/c680329964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670823999","title":"甘肃农垦药物碱厂与广州安信医药有限公司座谈交流","url":"https://stock-news.laohu8.com/highlight/detail?id=2670823999","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670823999?lang=zh_cn&edition=full","pubTime":"2026-09-28 18:09","pubTimestamp":1790590140,"startTime":"0","endTime":"0","summary":"近日，广州安信医药有限公司核心研发团队到药物碱厂有限公司开展实地参观并座谈交流。公司领导班子及研发、注册、生产相关项目负责人和技术人员参加座谈。本次面对面深度交流，有效打通了上下游信息壁垒，进一步了解掌握了全国麻精药品市场信息，明确了公司在全球麻精药品市场定位，开拓了今后发展思路和方向。广州安信医药对药物碱厂在原料药领域的研发实力与合规体系给予充分肯定。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-28/doc-initktnz9654871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","159938","BK1161","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236807","title":"劲方医药-B斥资318.55万港元回购11.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236807","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670236807?lang=zh_cn&edition=full","pubTime":"2026-09-28 18:05","pubTimestamp":1790589900,"startTime":"0","endTime":"0","summary":"劲方医药-B(02595.HK)发布公告，于2026年9月28日斥资318.55万港元回购11.6万股。 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260928/c680327857.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260928/c680327857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670236826","title":"劲方医药-B9月28日斥资318.55万港元回购11.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236826","media":"同花顺","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670236826?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:59","pubTimestamp":1790589540,"startTime":"0","endTime":"0","summary":"劲方医药-B(02595)发布公告，于2026年9月28日斥资318.55万港元回购11.6万股。 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260928/c680327719.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260928/c680327719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670235916","title":"劲方医药-B(02595)9月28日斥资318.55万港元回购11.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670235916","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670235916?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:53","pubTimestamp":1790589238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)发布公告，于2026年9月28日斥资318.55万港元回购11.6万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1574","09939","BK1515","02595","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670804152","title":"9月28日亚虹医药科技跌6.92%，国联医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670804152","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670804152?lang=zh_cn&edition=full","pubTime":"2026-09-28 16:42","pubTimestamp":1790584959,"startTime":"0","endTime":"0","summary":"证券之星消息，9月28日亚虹医药科技跌6.92%，收盘报13.71元，换手率2.83%，成交量16.16万手，成交额2.27亿元。重仓亚虹医药科技的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为国联基金的国联医疗健康混合A。国联医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800021528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1574","159760","09939","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670621286","title":"云顶新耀盘中涨超5%，AI医药规划发布及mRNA疫苗进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2670621286","media":"同花顺","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670621286?lang=zh_cn&edition=full","pubTime":"2026-09-28 13:24","pubTimestamp":1790573040,"startTime":"0","endTime":"0","summary":"9月28日，云顶新耀（01952.HK）盘中涨超5%，截至13时22分，涨5.20%，报29.14港元/股，成交额9600.80万港元。消息面上，工信部等十部门联合发布《医药工业发展“十五五”规划》，提出深化人 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260928/c680309632.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260928/c680309632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670286537","title":"医药韧性凸显！药ETF华宝（562050）逆市飘红，丽珠集团涨停！医疗器械局部强势，迈瑞、联影携手走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2670286537","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670286537?lang=zh_cn&edition=full","pubTime":"2026-09-28 13:11","pubTimestamp":1790572260,"startTime":"0","endTime":"0","summary":"制药板块顽强抗跌，场内唯一跟踪制药指数的药ETF华宝一度逆市飘红，创新药概念股丽珠集团涨停封板，健康元、康弘药业、普洛药业齐涨逾5%。把握超跌医药新机遇，投资工具关注：药ETF华宝：全市场唯一跟踪制药指数的ETF，“70%创新药+20%中药”独家配比，兼具创新药高成长及中药高股息。医疗ETF华宝：全市场医药医疗类ETF旗舰，Q2规模256.24亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-28/doc-initkarm3859610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PTH","159883","159938","BK1161","RSPH","09996","BK0188","IEIH","MEDX","562050","000513","BK1583","HART","09939","BK0187","BK1515","LGHT","GDOC","BK1574","MDEV","LNGR","BK1100","BK0239","AGNG","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670286867","title":"礼邦医药-B盘中跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670286867","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670286867?lang=zh_cn&edition=full","pubTime":"2026-09-28 13:03","pubTimestamp":1790571780,"startTime":"0","endTime":"0","summary":"9月28日，礼邦医药-B(09637.HK)盘中跌超5%，截至13时1分，跌5.33%，报23.46港元/股，成交额727.68万港元。 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260928/c680309095.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260928/c680309095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670283094","title":"同源康医药-B盘中跌超5%，董事长连续增持，齐鲁股权认购失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2670283094","media":"同花顺","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670283094?lang=zh_cn&edition=full","pubTime":"2026-09-28 12:04","pubTimestamp":1790568240,"startTime":"0","endTime":"0","summary":"9月28日，同源康医药-B(02410.HK)盘中跌超5%，截至12时0分，跌5.26%，报3.96港元/股，成交额339.03万港元。消息面上，董事长兼总裁吴豫生增持40万股，每股作价2.8157港元，总金额约112.63万 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260928/c680306712.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260928/c680306712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670728818","title":"劲方医药-B盘中跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670728818","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670728818?lang=zh_cn&edition=full","pubTime":"2026-09-28 10:39","pubTimestamp":1790563140,"startTime":"0","endTime":"0","summary":"9月28日，劲方医药-B（02595.HK）盘中跌超5%，截至10时37分，跌5.28%，报28.32港元/股，成交额3895.11万港元。 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260928/c680302383.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260928/c680302383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670540232","title":"星昊医药（920017）57.52万股限售股将于9月28日解禁，占总股本0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670540232","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670540232?lang=zh_cn&edition=full","pubTime":"2026-09-28 08:01","pubTimestamp":1790553718,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，星昊医药于9月28日将有57.52万股限售股份解禁，为公司股权激励期权行权，占公司总股本0.46%。最近一年内，该股累计解禁22.88万股，占总股本的0.18%。本次解禁后，公司还有136.24万股限售股份，占总股本1.09%。星昊医药主营业务：公司是一家从事高端药物制剂研发产业化服务的创新型企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800002052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1161","BK1515","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670401108","title":"股市必读：欧康医药新发布《投资者关系活动记录表》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670401108","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670401108?lang=zh_cn&edition=full","pubTime":"2026-09-28 03:44","pubTimestamp":1790538255,"startTime":"0","endTime":"0","summary":"公司公告汇总投资者关系活动记录表成都欧康医药股份有限公司于2026年9月23日举行特定对象调研活动，回应募投项目产能利用率、未来三年发展战略、欧盟GMP证书应用、海外市场拓展、原材料采购价格波动应对、股东减持计划影响及植物提取物行业发展机遇等问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","159938","09939","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409528","title":"股市必读：迪哲医药新发布《迪哲医药：关于高级管理人员减持股份计划公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409528","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409528?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:30","pubTimestamp":1790530233,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，迪哲医药报收于56.45元，下跌6.31%，换手率1.41%，成交量6.52万手，成交额3.74亿元。公司公告汇总：迪哲医药5名高级管理人员拟合计减持不超过353,091股，占总股本不超过0.0760%，减持期间为2026年11月2日至2027年2月1日。财务总监吕洪斌、副总经理陈素勤、QINGBEI ZENG、HONCHUNG TSUI、SHIH-YING CHANG合计持有公司股份1,400,961股，占总股本0.3012%。因个人资金需求，上述人员拟通过集中竞价方式减持不超过其持股数量的25%，合计减持不超过353,091股，占公司总股本不超过0.0760%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","09939","BK1161","159938","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670840938","title":"股市必读：津药药业新发布《津药药业股份有限公司关于上海上实（集团）有限公司及上海上实投资发展有限公司挂牌转让上海琉璃光医药发展有限公司100%股权的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670840938","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670840938?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:09","pubTimestamp":1790528951,"startTime":"0","endTime":"0","summary":"公司公告汇总津药药业股份有限公司关于上海上实（集团）有限公司及上海上实投资发展有限公司挂牌转让上海琉璃光医药发展有限公司100%股权的提示性公告上海上实（集团）有限公司及上海上实投资发展有限公司通过上海联合产权交易所公开挂牌转让上海琉璃光医药发展有限公司100%股权，信息披露起止日期为2026年9月24日至2026年10月29日。本次股权转让事项已依法依规进行信息正式披露，津药药业将密切关注进展并履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK0028","BK0012","BK0239","09939","BK1161","BK0102","BK1515","600488","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409924","title":"年内外资调研A股公司近6000次 外资机构调研路径呈现科技为主，消费、医药为辅的格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409924","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409924?lang=zh_cn&edition=full","pubTime":"2026-09-28 00:39","pubTimestamp":1790527140,"startTime":"0","endTime":"0","summary":"近日，为吸引更多境外中长期资金入市，促进国际投资者对沪市公司投资价值的了解，推动资本市场高水平对外开放，上交所再次组织开展“国际投资者赴境内调研上市公司”活动。来自英国、法国、新加坡等国近20家国际资管机构代表走进沪市科创企业一线，感受沪市科创企业坚实的经营基本面与多元增长动力。今年以来，外资机构调研A股上市公司的次数持续攀升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11215,202609283884541543.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11215,202609283884541543.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["09939","BK1515","02846","07233","82846","BK1147","BK1161","03130","02827","159938","02843","BK1610","399300","82822","83130","82823","83188","02823","02822","BK1574","82843","03188","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670401559","title":"国泰海通｜医药：WCLC大会：中国公司展现强劲竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2670401559","media":"国泰君安证券研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670401559?lang=zh_cn&edition=full","pubTime":"2026-09-27 22:33","pubTimestamp":1790519580,"startTime":"0","endTime":"0","summary":"报告导读：本次2026 WCLC大会，众多中国公司携旗下创新药亮相，展现出强大竞争力。回顾历年WCLC大会，中国研究占比持续提升。2026年WCLC大会于9/12-9/15举行，本次会议中国研究共有65项口头报告和2项主席讨论研究入选，近半数LBA报告为中国研究。本次WCLC大会康方生物发布了H2研究期中OS分析结果，亚组分析显示PV双抗AK112相比PD1单抗在高表达人群中有着更强的OS获益，且获益水平随着随访时间延长而提高。1L sqNSCLC：多种双抗展现竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["research"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MzEwMDEzNQ==&mid=2650541863&idx=3&sn=812187e3743e09a590051f8c4e29f6a2&chksm=891507241be141023c1c9fadf89655283dfce65cfa3259143ba2581cdf28773942246335b65f&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK0012","BK0183","BK1564","BK0184","BK0188","BK0028","BK0276","BK1161","09939","601211","BK1574","02611","BK1147","159938","BK0201","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790603889935,"stockEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":-0.023},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0095},{"period":"1year","weight":-0.1308},{"period":"ytd","weight":-0.0169}],"compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":-0.0003},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0065},{"period":"1year","weight":0.009},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医药,159938,医药股票,医药股票老虎,医药股票老虎国际,医药行情,医药股票行情,医药股价,医药股市,医药股票价格,医药股票交易,医药股票购买,医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}